Fresh analysis suggests that patients who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who halt conventional lifestyle plans.
Research printed in a leading medical journal demonstrates that while obese individuals can lose substantial amounts of their total mass while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"People buying these medications need to be cognizant of the danger of rapid weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment weight in about a year and a half.
Weighing Treatments
The study, which examined 37 of studies involving thousands of participants, contrasted the results of GLP-1 agonists with other pills.
Researchers emphasize that individuals who lose weight through dieting usually experience a slower creep back—approximately 100 grams monthly—after stopping.
Understanding the Fast Regain
Experts believe the mode of action of the jabs is key to understanding the heightened weight return.
GLP-1 drugs copy a natural hormone called GLP-1, which controls appetite.
"Artificially providing GLP-1 levels several times higher than the body's typical production might result in the system to produce less of its endogenous GLP-1, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement means appetite is no longer kept in check, making excessive eating much more probable."
A Lifelong Condition?
The NHS suggest the jabs for individuals with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals argue that, given the high risk of weight regain, the treatment should be considered life-long.
This perspective is echoed by drug manufacturers, who state that the findings "highlight the persistent character of obesity," similar to managing diseases like high blood pressure.
Patient Accounts
People who have come off the medication explain a sudden return of cravings.
"I experienced a trigger flipping and you become extremely hungry," said one woman.
This challenge is compounded if individuals have not developed lasting lifestyle or habit changes during therapy.
Growing Adoption
Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand remaining high.
- Use is greater among females than males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the medications through private healthcare rather than the NHS.
In conclusion, researchers stress that while these medications are powerful agents for weight loss, they are not a magic solution and maintained weight loss hinges on combined behavioural support.
